DDX3X alleviates doxorubicin‐induced cardiotoxicity by regulating Wnt/β‐catenin signaling pathway in an in vitro model

The life‐threatening adverse effects of doxorubicin (Dox) caused by its cardiotoxic properties limit its clinical application. DDX3X has been shown to participate in a variety of physiological processes, and it acts as a regulator of Wnt/β‐catenin signaling. However, the role of DDX3X in Dox‐induced...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Dandan, Li, Jiang, Guo, Liang, Liu, Jing, Wang, Shaochen, Ma, Xiuyuan, Song, Yunxuan, Liu, Ju, Hao, Enkui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539463/
https://www.ncbi.nlm.nih.gov/pubmed/35467791
http://dx.doi.org/10.1002/jbt.23077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539463/
https://www.ncbi.nlm.nih.gov/pubmed/35467791
http://dx.doi.org/10.1002/jbt.23077

Ejemplares similares